Mar 03, 2020 / 05:00PM GMT
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Well, hello once again. We're very, very happy to have Merck with us at the Cowen Conference again this year. Representing the company is Rob Davis, Chief Financial Officer; as well as Peter Dannenbaum, who heads up the Investor Relations effort.
So thank you so much for being with us today.
Questions and Answers:
Stephen Michael Scala - Cowen and Company, LLC, Research Division - MD & Senior Research AnalystSo given the fact that it's Super Tuesday, I thought I would start out with a bit of a pricing question, and maybe you could just articulate for us how pricing has trended over the last 3 years, how you look at it over the next 3 years, and does it change -- does the answer change if Bernie Sanders is the next president?
Robert M. Davis - Merck & Co., Inc. - Executive VP of Global Services & CFO
Well, if you look at where we've been, and we've talked about this in the past, obviously,